Cabozanib 20mg Tablet
By Cabozanib
Rx
30 Tablet in a Bottle

Composition
Cabozantinib(20mg)

Manufacturer - BDR Pharmaceuticals Internationals Pvt
407-408, Sharda Chambers, New Marine Lines, Mumbai 400 020 (Maharashtra), New Marine Lines, Marine Lines, Mumbai, Maharashtra 400020

Expires on or after
July, 2025

liver
Cabozanib 20mg Tablet should be used carefully in individuals with liver disease. It may be necessary to adjust the dose of Cabozanib 20mg Tablet, so it is important to seek advice from your doctor. If you have a pre-existing liver condition or a history of liver problems, inform your doctor before starting this medication. Cabotib 20 mg Tablet 30's has the potential to cause liver damage when used alongside nivolumab. Therefore, caution is advised when using this medication in patients with moderate liver impairment. Your doctor may recommend liver function tests to monitor the impact of the treatment on your liver.

kidney
Cabozanib 20mg Tablet is safe for use in patients with kidney disease. Inform your doctor if you have kidney issues before taking this medicine; dosage adjustment may be needed.

alcohol
It is advisable to avoid alcohol while taking Cabozanib 20mg Tablet as it may lead to severe side effects. Always consult your doctor for guidance.

driving
It is not clear if Cabozanib 20mg Tablet affects driving ability. Avoid driving if you have symptoms affecting focus and reactions. Cabotib 20 mg Tablet 30's may cause dizziness and vision issues, so avoid driving until sure it's safe.

pregnancy
Cabozanib 20mg Tablet may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing this medication. It is important to consult your doctor, especially if you are pregnant or planning to become pregnant, as Cabozanib 20mg Tablet may cause harm to the fetus. Effective birth control methods should be used while taking this medication, and it is advised not to get pregnant for at least four months after discontinuing Cabozanib 20mg Tablet.

breastfeeding
Cabozanib 20mg Tablet may be unsafe during breastfeeding as it can pass into breastmilk and harm the baby. Avoid nursing while on this medication and for at least four months after the last dose. It is advisable to consult your doctor before using Cabozanib 20mg Tablet.
Habit Forming | No |
Chemical Class | Diarylethers |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹5040
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024